Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 2 (2010) EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION Abstract  PDF (Eng)  similar documents
A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova
"... Aim. To study influence of beta-blockers carvedilol and metoprolol tartrate on platelet ..."
 
Vol 5, No 4 (2009) METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER Abstract  similar documents
B. N. Garifullin, A. N. Zakirova, F. S. Zarudij
"... of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment ..."
 
Vol 4, No 2 (2008) BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL Abstract  similar documents
A. N. Zakirova, F. S. Zarudij, B. N. Garifullin
"... Approaches evolution to studying of beta-blockers influence on emplatelet/em aggregation is reviewed ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... on emcarvedilol/em or emmetoprolol/em in patients with arterial hypertension (HT) 1-2 degrees and overweight/obesity ..."
 
Vol 5, No 3 (2009) EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS Abstract  similar documents
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
"... Aim. To study effects of emcarvedilol/em and emmetoprolol/em on vegetative regulation of heart ..."
 
Vol 6, No 3 (2010) ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY Abstract  similar documents
V. A. Nevzorova, E. S. Potapova, O. V. Nastradin
"... Aim. To evaluate an efficacy of the 24-week antihypertensive therapy based on the emcarvedilol/em ..."
 
Vol 4, No 5 (2008) CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... for comparable study of efficacy and safety of therapies based on β-blockers (emcarvedilol/em and emmetoprolol/em ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... Aim. To evaluate antihypertensive and metabolic effects of the therapy based on emcarvedilol/em (C ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... Aim. To compare two therapies based on emcarvedilol/em or emmetoprolol/em in hypertensive patients ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... and various beta-blockers (atenolol, emmetoprolol/em, bisoprolol). These beta-blockers were changed for emcarvedilol/em ..."
 
Vol 3, No 4 (2007) EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
"... with CHF. emCarvedilol/em in comparison with emmetoprolol/em was more effective in myocardial remodeling prevention ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... , emmetoprolol/em, simvastatin) during 2 years after discharge from the hospital. Patients of the first studied ..."
 
Vol 7, No 3 (2011) COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) Abstract  similar documents
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva
"... Aim. To compare the efficacy and safety of emcarvedilol/em in men and women with mild to moderate ..."
 
Vol 5, No 2 (2009) COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA Abstract  similar documents
A. A. Anderzhanova, J. V. Gavrilov, V. A. Sulimov
"... adrenoblockers (betaxolol and emmetoprolol/em emtartrate/em) in patients with arterial hypertension (HT) of 1-2 degree ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS Abstract  similar documents
O. L. Barbarash, M. V. Zykov
"... emmetoprolol/em emtartrate/em (CRMT) in patients with arterial hypertension of 1-3 degree. Material and methods. 603 ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... The review presented the importance of emcarvedilol/em using in terms of renoprotection in renal ..."
 
Vol 1, No 3 (2005) COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich
"... Aim. To study efficiency and safety of new drug of long acting emmetoprolol/em emtartrate/em, “Egilok retard ..."
 
Vol 2, No 3 (2006) HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. I. Markova, A. I. Radzevich
"... Aim. To evaluate the influence of emcarvedilol/em (Talliton, Egis, Hungary) on daily profile of blood ..."
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
"... treatment with emmetoprolol/em emtartrate/em in patients with hypertension (HT) degree 1-2. Material and Methods ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... Aim. To study efficacy and safety of beta-blocker with vasodilating properties emcarvedilol/em ..."
 
Vol 6, No 3 (2010) WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL? Abstract  similar documents
E. V. Kuleshova
"... Relationship of emmetoprolol/em clinical efficacy with its different salts (emtartrate/em, succinate ..."
 
Vol 13, No 6 (2017) THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
A. N. Zakirova, B. N. Garifullin, N. E. Zakirova
"... in experimental data. emCarvedilol/em is a third-generation beta-blocker with additional pleiotropic and antioxidant ..."
 
Vol 4, No 2 (2008) COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION Abstract  similar documents
M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva
"... Aim. To compare efficacy of emcarvedilol/em and bisoprolol in patients with chronic heart failure (CHF ..."
 
Vol 3, No 3 (2007) TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY Abstract  similar documents
V. E. Oleinikov, V. A. Budanova, A. V. Kulyutsin
"... heart rate variability (HRV) and efficacy of emmetoprolol/em emtartrate/em in long-acting presentation (Egilok ..."
 
Vol 4, No 5 (2008) CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
M. V. Soura
"... ’s comparative cost analysis on emmetoprolol/em emtartrate/em (Betaloc) and emmetoprolol/em succinate (Betaloc ZOK) usage ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Aim. To compare antihypertensive and metabolic effects of long-term treatment with emcarvedilol/em ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
"... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) emcarvedilols/em with estimation of their serum level. And to study ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... or beta-blocker emcarvedilol/em in patients with chronic heart failure (CHF) due to dilated cardiomyopathy ..."
 
Vol 1, No 3 (2005) CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL Abstract  similar documents
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
"... . The average daily doses were 5,7+0,8 mg for and 32,6+3,4 mg for emcarvedilol/em. The duration of the observation ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... (EF) of long-term treatment with emcarvedilol/em or bisoprolol in patients with arterial hypertension (HT ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... Aim. To evaluate a short-term efficacy and safety of nebivolol and emcarvedilol/em in hypertensive ..."
 
Vol 3, No 1 (2007) RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY Abstract  similar documents
M. L. Maximov
"... of emmetoprolol/em, bisoprolol and emcarvedilol/em had been proven in CHF therapy. Nebivolol was effective in elderly ..."
 
Vol 4, No 1 (2008) EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE Abstract  similar documents
S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash
"... Aim. To evaluate the effect of emmetoprolol/em emtartrate/em on blood pressure (BP) and cognitive function ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... Aim. To study effect of cardioselective β-adrenoblocker emmetoprolol/em emtartrate/em (in retarded ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... is surveyed. Author presents a review of data about selective β1-blocker, emmetoprolol/em succinate (Betalok ZОК ..."
 
Vol 5, No 4 (2009) EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE Abstract  similar documents
N. J. Borovkova, N. N. Borovkov, T. I. Maslov
"... , emmetoprolol/em emtartrate/em, amlodipine bensilate and rilmenidine dihydrogen phosphate in hypertensive patients ..."
 
Vol 3, No 4 (2007) EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova
"... – emmetoprolol/em (Metocard), 50-200 mg/d. Diuretics were added when necessary. Ambulatory blood pressure (BP ..."
 
Vol 8, No 6 (2012) TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE Abstract  similar documents
O. D. Ostroumova, G. N. Shchukina, V. M. Fomina
"... Advantages of emmetoprolol/em succinate in patients with chronic heart failure (CHF) are covered ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... on emmetoprolol/em. Patients were randomized in 2 groups (G1 and G2). The initial emmetoprolol/em dose was 50 mg in G1 ..."
 
Vol 2, No 3 (2006) EFFECTS OF AMLODIPIN AND METOPROLOL ON AUTONOMIC SYSTEM IN EMOTIONAL AND COLD TESTS IN HYPERTENSIVE PATIENTS WITH DIFFERENT PSYCHOLOGICAL PROFILE Abstract  similar documents
M. P. Rubanova, V. R. Veber, I. A. Suhenko, P. M. Gubskaya
"... Aim. To asses effects of amlodipin and emmetoprolol/em on autonomic system in emotional and cold tests ..."
 
Vol 4, No 1 (2008) VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
E. D. Golovanova
"... Retard, 1,5 mg/d), emmetoprolol/em emtartrate/em (Egilok Retard, 50 mg/d) and combined therapy with indapamide ..."
 
Vol 11, No 1 (2015) EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Andreev, D. A. Sychev
"... Evaluation of emplatelet/em function with subsequent modification of antiplatelet therapy regimen ..."
 
Vol 2, No 3 (2006) CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES Abstract  similar documents
P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian
"... results into emplatelets/em activation and thrombus formation. Aspirin - one of the most widely used ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... Council on the significance of testing of emplatelet/em functional activity in the prevention of cardiovascular ..."
 
Vol 9, No 3 (2013) TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN Abstract  similar documents
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
 
Vol 6, No 5 (2010) WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov
"... ) — emcarvedilol/em, group 3 (n=30) — nebivolol. Study duration was 6 months. Clinical examination (physical ..."
 
Vol 7, No 6 (2011) INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. G. Tregubov, S. G. Kanorskiy, V. M. Pokrovskiy
"... Aim. To estimate emmetoprolol/em succinate effect on regulatory and adaptive status (RAS) of patients ..."
 
Vol 3, No 2 (2007) NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS Abstract  similar documents
Y. V. Gavrilov, V. A. Sulimov, V. I. Makolkin
"... and 50 patients started to take emmetoprolol/em in initial dose of 50 mg twice daily. Duration of treatment ..."
 
Vol 2, No 2 (2006) CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION Abstract  similar documents
V. E. Oleynikov, V. A. Budanova, A. V. Kulucin
"... Aim. To study antihypertensive efficacy of long-acting emmetoprolol/em, its influence on heart rate ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... was estimated by effects on ADP-induced emplatelet/em aggregation initially and after 2 weeks of treatment with each ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... The review presents recent data on the usage of emplatelet/em functional tests in patients with ischemic ..."
 
Vol 12, No 6 (2016) THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev
"... . All patients in the study received emmetoprolol/em emtartrate/em (100 mg daily). Nicorandil was added (10 mg BID ..."
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... emplatelet/em aggregative reactivity (RPAR). Material and methods. Patients (n=40) with ischemic heart disease ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... antiplatelet effect was evaluated by spontaneous and ADP-induced emplatelet/em aggregation assessment. emPlatelet/em ..."
 
Vol 7, No 6 (2011) ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS Abstract  similar documents
L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo
"... Aim. To analyze the literary and own data about clopidogrel influence on emplatelets/em during ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... into the 2nd group (G2). emPlatelet/em aggregation was evaluated by Born's method (inducers of emplatelet/em ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... . Antiplatelet efficacy of ASA medicines were estimated by effects on spontaneous and ADP-induced emplatelet/em ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... ,3 y.o. in average). emPlatelet/em aggregation was assessed by the Born’s method. Level of arachidonic ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... Aim. To study the features of the state of hemostasis and emplatelet/em enzymes activity ..."
 
Vol 8, No 4 (2012) COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»  similar documents
D. V. Nebieridze
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... after acute coronary syndrome (ACS) is characterized by high level of emplatelet/em reactivity, which ..."
 
Vol 3, No 4 (2007) RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
"... Aim. To estimate the prevalence of atherothrombotic complications depending on emplatelet/em ..."
 
Vol 4, No 3 (2008) COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME Abstract  similar documents
E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky
"... metabolism, emplatelet/em aggregation in patients with arterial hypertension (HT) and metabolic syndrome (MS ..."
 
Vol 12, No 5 (2016) Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine Abstract  similar documents
O. V. Zimnitskaya, M. M. Petrova
"... combination on the level of soluble emplatelet/em-endothelial cell adhesion molecule of the first type (sPECAM-1 ..."
 
Vol 16, No 1 (2020) Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients Abstract  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin
 
Vol 2, No 2 (2006) COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
M. N. Mamedov, T. V. Ektova, O. A. Litinskaya, T. Sh. Dzhakhangirov, O. V. Kosmatova
"... resistance, endothelium function, markers of inflammation, and emplatelet/em activity in patients with metabolic ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... 6133 polymorphism is not associated with increased emplatelet/em aggregation activity after CABG and does ..."
 
Vol 5, No 4 (2009) THE CAMELLIA TRIAL: SCIENTIFIC VALUE AND RECOMMENDS FOR PRACTITIONER Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, S. A. Shalnova, R. G. Oganov
"... emкарведилоле/em и метопрололе. ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
 
Vol 12, No 5 (2016) Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention Abstract  similar documents
E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva
"... on-treatment emplatelet/em reactivity (according to VerifyNow®), PAI-1 and vWF presenting activity may be useful ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... Aim. To study the prevalence of high residual emplatelet/em reactivity (HRPR) during the dual ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
 
Vol 5, No 2 (2009) EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
G. F. Andreeva, A. D. Deev, V. M. Gorbunov
"... received antihypertensive monotherapy with diltiazem, amlodipine, enalapril, lisinopril, emmetoprolol/em ..."
 
Vol 4, No 3 (2008) URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES Abstract  similar documents
M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov
"... , emmetoprolol/em, nebivolol) in patients with arterial hypertension (HT) and concomitant benign prostatic ..."
 
Vol 4, No 3 (2008) INFLUENCE OF COMBINED ANTIHYPERTENSIVE AND ANTIDEPRESSANT THERAPY ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION, ANXIETY AND DEPRESSION Abstract  similar documents
Y. A. Vasyuk, T. V. Dovzenko, E. A. Nesterova, I. A. Sadulaeva, K. V. Tarasova
"... Aim. To assess influence of combined antihypertensive (captopril or emmetoprolol/em) and antidepressant ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... Aim. To evaluate the functional activity of emplatelets/em by the optical standard aggregatometry ..."
 
Vol 13, No 6 (2017) THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL Abstract  similar documents
I. V. Gribkova, M. V. Davydovskaya
"... (PDI) serves an essential role in the processes of thrombus formation. PDI is secreted by emplatelets/em ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... of cardiovascular complications and activity of emplatelet/em aggregation, to assess safety of dual antiplatelet therapy ..."
 
Vol 13, No 4 (2017) PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW Abstract  similar documents
I. S. Yavelov
"... and safety of prolonged use of a combination of acetylsalicylic acid and blocker P2Y12 emplatelet/em receptor ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... , and no recommendations for their practical use. It is necessary to work out unified procedure to assess emplatelet/em function ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... syndrome (ACS) and having poorly reduced emplatelet/em aggregation (proven by optical aggregometry) in response ..."
 
Vol 15, No 2 (2019) The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov
"... and emplatelet/em P2Y12 receptor inhibitors. One of the first drugs from the group of P2Y12 receptor inhibitors ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... (55.0%) occupied the leading position in the group of beta-blockers. emMetoprolol’s/em prescription rate ..."
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... in enteric form at a dose of 100 mg. To determine the sensitivity to ASA emplatelet/em aggregation induced ..."
 
Vol 6, No 2 (2010) NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER Abstract  similar documents
T. Műnzel, T. Gori
"... рынок США. Как и emкарведилол/em, небиволол относится к третьему поколению β-блокаторов, обладающих наряду с ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... of acetylsalicylic acid (100 mg/day) and ticagrelor 90 mg twice a day. ADP-induced emplatelet/em aggregation (1.25 and 2 ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... emPlatelets/em play an important role in the pathogenesis of atherosclerosis. They are involved ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of emplatelet/em receptors ..."
 
Vol 14, No 2 (2018) THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT Abstract  similar documents
M. S. Soboleva, Е. E. Loskutova
"... drugs was studied. Results. Among β-blockers the leaders were emmetoprolol/em (from 2% to 30 ..."
 
Vol 4, No 4 (2008) INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. R. Veber, M. P. Rubanova, M. N. Kopina, S. V. Zhmajlova, D. P. Shmatko, I. V. Prozorova
"... and echocardiography examination was performed before and after 1, 3 and 6 months of therapy (emmetoprolol/em, nebivolol ..."
 
Vol 15, No 4 (2019) Antihypertensive Drug Utilization in Two Districts of Northern Cyprus Abstract  PDF (Eng)  similar documents
M. Tamirci, R. Demirdamar
"... . According to the ATC-5 subclassification, the most common prescribed antihypertensives were emmetoprolol/em (16 ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... allelic variants were detected by the method of real-time polymerase chain reaction. emPlatelet/em functional ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... of CYP3A4 isoenzyme activity and CYP2C19 polymorphisms on emplatelet/em aggregation. Material and methods ..."
 
Vol 14, No 2 (2018) New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion Abstract  similar documents
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko
"... option of which until recently was an additional treatment with P2Y12 emplatelet/em receptors blockers ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... (5–10 mg/day) in combination with indapamide retard (1.5 mg/day) and emmetoprolol/em succinate (50–100 mg ..."
 
Vol 15, No 2 (2019) Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov
"... for patients after AMI, the second place took emmetoprolol/em, its prescription was two times less than bisprolol ..."
 
Vol 13, No 6 (2017) SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis Abstract  similar documents
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina
"... of acute cardiovascular events during smoking include the activation of inflammation, emplatelet/em aggregation ..."
 
1 - 100 of 115 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)